Details for: ALPROLIX
Company: SANOFI-AVENTIS CANADA INC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02422913 | ALPROLIX | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN | 500 UNIT / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
02422913 | ALPROLIX | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN | 500 UNIT / VIAL | KIT | INTRAVENOUS |
02422921 | ALPROLIX | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN | 1000 UNIT / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
02422921 | ALPROLIX | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN | 1000 UNIT / VIAL | KIT | INTRAVENOUS |
02422948 | ALPROLIX | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN | 2000 UNIT / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
02422948 | ALPROLIX | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN | 2000 UNIT / VIAL | KIT | INTRAVENOUS |
02422956 | ALPROLIX | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN | 3000 UNIT / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
02422956 | ALPROLIX | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN | 3000 UNIT / VIAL | KIT | INTRAVENOUS |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.